A. Bajaj

发表

Trends in mortality from stroke in Austria, 1980–2008

E. Schernhammer, T. Waldhör, G. Haidinger, 2010, Wiener klinische Wochenschrift.

Clinical Management of Hypertriglyceridemia in the Prevention of Cardiovascular Disease and Pancreatitis

D. Soffer, V. Kulkarni, Taher Modarressi, 2021, Current Atherosclerosis Reports.

Lipoprotein(a) and Risk of Myocardial Infarction and Death in Persons with Chronic Kidney Disease: Findings from the Chronic Renal Insufficiency Cohort (CRIC) Study

Jinbo Chen, A. Go, Mahboob Rahman, 2017 .

From supravalvular to valvular aortic stenosis: are statins contributing to the phenotypic shift in homozygous familial hypercholesterolaemia?

M. Cuchel, A. Bajaj, 2022, European heart journal.

Deep Apolipoprotein Proteomics to Uncover Mechanisms of Coronary Disease Risk.

D. Rader, Sumeet A. Khetarpal, A. Bajaj, 2017, Journal of the American College of Cardiology.

Antisense oligonucleotides for atherosclerotic disease

D. Rader, A. Bajaj, 2020, Nature Medicine.

Homozygous familial hypercholesterolemia: what treatments are on the horizon?

M. Cuchel, A. Bajaj, 2020, Current opinion in lipidology.

Advancements in the Treatment of Homozygous Familial Hypercholesterolemia

M. Cuchel, A. Bajaj, 2022, Journal of atherosclerosis and thrombosis.

Can changes in the plasma lipidome help explain the cardiovascular benefits of the Mediterranean diet?

D. Rader, A. Bajaj, 2017, The American journal of clinical nutrition.

Feasibility and outcomes from using a commitment devices and text message reminders to increase adherence to time-restricted eating: A randomized trial.

Alexander C. Fanaroff, S. Adusumalli, Monika Sanghavi, 2023, American heart journal.

Parkinson’s disease and cancer risk: a systematic review and meta-analysis

E. Schernhammer, J. Driver, A. Bajaj, 2010, Cancer Causes & Control.

Implementation of a Machine-Learning Algorithm in the Electronic Health Record for Targeted Screening for Familial Hypercholesterolemia

D. Rader, D. Soffer, K. Myers, 2021, Circulation. Cardiovascular quality and outcomes.

Phenome-wide association analysis suggests the APOL1 linked disease spectrum primarily drives kidney-specific pathways.

David L. Birtwell, Jinbo Chen, D. Rader, 2020, Kidney international.

Lipoprotein(a) and Risk of Myocardial Infarction and Death in Chronic Kidney Disease: Findings From the CRIC Study (Chronic Renal Insufficiency Cohort)

M. Budoff, Jinbo Chen, A. Go, 2017, Arteriosclerosis, thrombosis, and vascular biology.

A systematic review of the natural history and biomarkers of primary lecithin:cholesterol acyltransferase deficiency

Jinbo Chen, D. Rader, K. Stylianou, 2022, Journal of lipid research.

Validation of a Light Questionnaire with Real-life Photopic Illuminance Measurements: the Harvard Light Exposure Assessment Questionnaire

Archna Bajaj, Bernard Rosner, B. Rosner, 2011, Cancer Epidemiology, Biomarkers & Prevention.

APOL1 and Cardiovascular Disease: A Story in Evolution.

S. Damrauer, K. Suszták, A. Bajaj, 2017, Arteriosclerosis, thrombosis, and vascular biology.

Circulating vitamin D, supplement use, and cardiovascular disease risk: the MrOS Sleep Study.

E. Barrett-Connor, P. Cawthon, D. Bauer, 2014, The Journal of clinical endocrinology and metabolism.

Lipoprotein(a) and Oxidized Phospholipids: Partners in Crime or Individual Perpetrators in Cardiovascular Disease?

D. Rader, A. Bajaj, 2023, Journal of the American College of Cardiology.

Lipoprotein(a) and the Risk for Recurrent Atherosclerotic Cardiovascular Events Among Adults With CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

Mahboob Rahman, K. Monda, P. Muntner, 2023, Kidney Medicine.

Shift Work, Chronotype, and Melatonin Rhythm in Nurses

W. Willett, S. Hankinson, W. Gauderman, 2019, Cancer Epidemiology, Biomarkers & Prevention.

Recent advances in the management and implementation of care for familial hypercholesterolaemia.

M. Cuchel, N. Lan, A. Bajaj, 2023, Pharmacological research.

Lipids, Apolipoproteins, and Risk of Atherosclerotic Cardiovascular Disease in Persons With CKD.

A. Go, Mahboob Rahman, D. Rader, 2019, American journal of kidney diseases : the official journal of the National Kidney Foundation.

A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice.

M. Boffa, M. Koschinsky, A. Bajaj, 2024, Journal of clinical lipidology.

Establishing a patient‐centered, multidisciplinary pharmacogenomics clinic in an academic health system: Successes, challenges, and future direction

S. Tuteja, A. Bajaj, Glenda Hoffecker, 2023, JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY.